Literature DB >> 10213314

Natural endogenous reverse transcription of HIV-1.

H Zhang1, G Dornadula, R J Pomerantz.   

Abstract

Mechanisms involved with human immunodeficiency virus type I (HIV-1) sexual transmission are not fully defined. We have demonstrated that endogenous reverse transcription of lenti-viruses can occur within the intact virion. This takes place before direct infection of the target cells. In a biochemically active process, endogenous reverse transcription occurs in HIV-1 virions in specific microenvironments. In virions without non-physiological permeabilization, endogenous reverse transcription can occur and has been entitled natural endogenous reverse transcription (NERT). This molecular mechanism dramatically increases HIV-1 infection in initially-quiescent peripheral blood mononuclear cells, as well as non-proliferating cells such as macrophages. This molecular process may augment sexually transmission of HIV-1, as HIV virion particles in genital secretions are shown to have increased endogenous reverse transcripts and NERT is potently stimulated. Further studies are necessary to determine whether this molecular mechanism is critical in vivo for sexual transmission of this human lenti-viral agent.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10213314     DOI: 10.1016/s0165-0378(98)00062-x

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  16 in total

1.  De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity.

Authors:  Berthony Deslouches; Shruti M Phadke; Vanja Lazarevic; Michael Cascio; Kazi Islam; Ronald C Montelaro; Timothy A Mietzner
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

Review 2.  Early events of HIV-1 infection: can signaling be the next therapeutic target?

Authors:  Kate L Jones; Redmond P Smyth; Cândida F Pereira; Paul U Cameron; Sharon R Lewin; Anthony Jaworowski; Johnson Mak
Journal:  J Neuroimmune Pharmacol       Date:  2011-03-05       Impact factor: 4.147

3.  Restoration of wild-type infectivity to human immunodeficiency virus type 1 strains lacking nef by intravirion reverse transcription.

Authors:  M Khan; M Garcia-Barrio; M D Powell
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Molecular interactions of human immunodeficiency virus type 1 with primary human oral keratinocytes.

Authors:  Edward A Acheampong; Zahida Parveen; Lois W Muthoga; Vivian Wasmuth-Peroud; Mehrnush Kalayeh; Adnan Bashir; Robert Diecidue; Muhammad Mukhtar; Roger J Pomerantz
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  Structural analyses of purified human immunodeficiency virus type 1 intracellular reverse transcription complexes.

Authors:  Milan V Nermut; Ariberto Fassati
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

6.  Chimeric human immunodeficiency virus type 1 (HIV-1) virions containing HIV-2 or simian immunodeficiency virus Nef are resistant to cyclosporine treatment.

Authors:  Mahfuz Khan; Lingling Jin; Ming Bo Huang; Lesa Miles; Vincent C Bond; Michael D Powell
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

Review 7.  Formation of the tRNALys packaging complex in HIV-1.

Authors:  Lawrence Kleiman; Christopher P Jones; Karin Musier-Forsyth
Journal:  FEBS Lett       Date:  2010-01-21       Impact factor: 4.124

8.  Cell factors stimulate human immunodeficiency virus type 1 reverse transcription in vitro.

Authors:  David Warrilow; Luke Meredith; Adam Davis; Christopher Burrell; Peng Li; David Harrich
Journal:  J Virol       Date:  2007-11-28       Impact factor: 5.103

9.  Specific implications of the HIV-1 nucleocapsid zinc fingers in the annealing of the primer binding site complementary sequences during the obligatory plus strand transfer.

Authors:  Julien Godet; Nick Ramalanjaona; Kamal K Sharma; Ludovic Richert; Hugues de Rocquigny; Jean-Luc Darlix; Guy Duportail; Yves Mély
Journal:  Nucleic Acids Res       Date:  2011-05-04       Impact factor: 16.971

Review 10.  When is it time for reverse transcription to start and go?

Authors:  Marylène Mougel; Laurent Houzet; Jean-Luc Darlix
Journal:  Retrovirology       Date:  2009-03-04       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.